![](/img/cover-not-exists.png)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., Bardelli, A.Volume:
26
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2008.18.0786
Date:
December, 2008
File:
PDF, 261 KB
english, 2008